4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-18-036516
Director sold 10,000 shares at $55.16 ($551,600)
- Director acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
CHESS ROBERT · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-06-05 | Exercise or conversion : show line 1 in the form | +10,000 | $14.26 | $142,600 | 284,223 | D |
| 2018-06-05 | Sale : show line 2 in the form | −10,000 | $55.16 | $551,600 | 274,223 | D |
| Open-market sales · 10,000 sh · avg $55.16 · $551,600 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-06-05 | Exercise or conversion : show line 3 in the form Stock Option | −10,000 | 0 | D |
Loading xslF345X03/doc4.xml…